FindTrial
Sign In

The Effect of Erector Spinae Plane Block on Postoperative Delirium and Recovery Quality in Elderly Patients Undergoing Transurethral Resection of the Prostate.

The Effect of Erector Spinae Plane Block on Postoperative Delirium and Recovery Quality in Elderly Patients Undergoing Transurethral Resection of the Prostate.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120841
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group C (control group):Sufentanil alone was used for perioperative analgesia in patients undergoing transurethral resection of the prostate.
Group T1 (butorphanol tartrate combined with ESPB group):Butorphanol tartrate combined with erector spinae plane block for perioperative analgesia in patients undergoing transurethral resection of the
Group T2 (sufentanil combined with ESPB group):Sufentanil combined with erector spinae plane block for perioperative analgesia in patients undergoing transurethral resection of the prostate

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective transurethral resection of the prostate under general anesthesia. 2.Aged 65 years or older; 3.American Society of Anesthesiologists (ASA) physical status Grade ? to ?; 4.Written informed consent was obtained from the patients or their legal representatives.

Exclusion criteria

Exclusion criteria: 1.Patients with cognitive or mental dysfunction that is expected to prevent adherence to the study protocol. 2.Having contraindications to butorphanol tartrate or routine postoperative analgesic drugs. 3.Patients with contraindications to ESPB, such as spinal deformity, coagulopathy, infection at the puncture site, or psychiatric disorders that prevent cooperation. 4.Patients with a history of allergy to local anesthetics or drugs used intraoperatively. 5.Patients with severe renal, hepatic, or cardiovascular diseases.

Design outcomes

Primary

MeasureTime frame
Perioperative quality of recovery;Delirium within 48 hours postoperatively;—

Secondary

MeasureTime frame
Systemic inflammatory level;Perioperative vital sign parameters;Serum inflammatory cytokines (interleukin-10 [IL-10]/tumor necrosis factor-a [TNF-a]);Drug consumption;—

Countries

China

Contacts

Public ContactSun Defeng

The First Affiliated Hospital of Dalian Medical University

sdf-yl@163.com+86 411 83635963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026